The chemical class known as TDRKH Activators encompasses a diverse array of compounds that influence the activity of the Tudor and KH domain-containing protein (TDRKH). These activators are not direct stimulants of TDRKH but interact with various cellular mechanisms and molecular pathways to create an environment conducive to its activation. This chemical class includes inhibitors of enzymes responsible for DNA methylation and histone modification, which can result in changes to chromatin structure and gene expression patterns. Such alterations can increase the transcription of genes that are involved in the regulation or function of TDRKH, thereby modulating its activity. Additionally, the class includes compounds that can affect signaling pathways, leading to changes in the phosphorylation status of proteins and the activation of transcription factors that may govern TDRKH's expression or function.
Members of this chemical class can also interact with cellular energy sensors and metabolic regulators, thereby altering the cellular energy state and indirectly stimulating pathways that intersect with TDRKH's activities. Furthermore, these activators can impact protein turnover by modulating proteasome activity, leading to the stabilization of proteins that either regulate or are involved in the same pathways as TDRKH. By influencing the stability and function of these regulatory proteins, TDRKH activators can play a role in orchestrating the cellular processes that are critical for TDRKH's function. The broad range of actions exhibited by this chemical class reflects the complex regulatory networks within which TDRKH operates, and their effects underscore the multifaceted nature of cellular signaling and gene expression control. Through these various mechanisms, TDRKH Activators can contribute to the regulation of TDRKH, affecting its role in essential cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase (HDAC) inhibitor that modifies chromatin structure, which could possibly activate TDRKH by enhancing transcription of genes that regulate or interact with it. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A tyrosine kinase inhibitor that affects various signaling pathways, and could possibly activate TDRKH by altering the phosphorylation state of proteins that modulate its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that disrupts downstream signaling and could possibly activate TDRKH by affecting cellular processes that influence its function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that induces autophagy and could possibly activate TDRKH by impacting protein turnover, including proteins that regulate TDRKH. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Modulates proteasome activity and alters protein degradation pathways, which could possibly activate TDRKH by affecting proteins that interact with or regulate it. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor that leads to changes in chromatin structure and gene expression, which could possibly activate TDRKH by affecting its activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
An HDAC inhibitor that influences gene expression and chromatin remodeling, which could possibly activate TDRKH by indirectly enhancing its function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that stabilizes proteins and could possibly activate TDRKH by influencing the stability of proteins that interact with it. | ||||||